Publication date: Jul 15, 2025
Proteolytic cleavage by furin-like proteases is a crucial first step in the posttranslational modification of various glycoproteins found in enveloped emerging viruses, such as SARS-CoV-2 and highly pathogenic avian influenza A viruses (IAV). Here, we explored the capacity of host cell proteins identified by cell surface proximity ligation to limit the proteolytic cleavage of the SARS-CoV-2 spike and the IAV H5N1 hemagglutinin (HA). When co-expressed with recombinant SARS-CoV-2 spike protein, Prom1, Axl, and Ly75 suppress its proteolytic cleavage, whereas cleavage of HA was only reduced by Prom1. Co-immunoprecipitation assays suggest that Axl and Prom1 may form a complex with furin. Alteration of Prom1, Axl and Ly75 expression levels in Calu3 cells affected entry of SARS-CoV-2 S pseudotyped VLP and to a lesser extent, SARS-CoV-2 virions. In contrast, Prom1 levels did not affect entry of H5N1 VLPs or H5N1 virions. Our data highlight the differential capacity of SARS-CoV-2 and IAV H5N1 to cope with newly identified host restriction factors of furin activity.

Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | host |
| disease | MESH | avian influenza |
| disease | IDO | protein |
| disease | MESH | infections |
| disease | IDO | process |
| pathway | KEGG | Virion |
| drug | DRUGBANK | Calcium |
| drug | DRUGBANK | Serine |
| disease | MESH | death |
| disease | MESH | Inflammation |
| drug | DRUGBANK | Coenzyme M |
| disease | IDO | assay |
| drug | DRUGBANK | Trypsin |
| disease | IDO | biological process |
| drug | DRUGBANK | Albendazole |
| disease | IDO | cell |
| drug | DRUGBANK | Aspartame |
| disease | IDO | site |
| disease | IDO | infection |
| disease | MESH | SARS CoV 2 infection |
| drug | DRUGBANK | Gonadorelin |
| drug | DRUGBANK | Influenza A virus |